Regeneron Pharmaceuticals | REGN - Capital Y Las Reservas





Capital Y Las Reservas Cambio Fecha
AbbVie USD -5.94B 721M 2026-06
Agenus USD -199.08M 22.15M 2026-06
Agios Pharmaceuticals USD 1.03B 83.09M 2026-06
Alnylam Pharmaceuticals USD 3.6B 2.25B 2026-09
Amgen USD 11.69B 2.5B 2026-06
Astellas Pharma JPY 1.94T 113.64B 2026-06
AstraZeneca USD 51.73B 1.43B 2026-09
Biogen USD 19.04B 194.3M 2026-09
BioMarin Pharmaceutical USD 6.32B 109.58M 2026-06
Bristol-Myers Squibb USD 23.4B 1.08B 2026-09
Eli Lilly USD 40.27B 6.39B 2026-09
Gilead Sciences USD 13.04B 1.3B 2026-09
GlaxoSmithKline GBP 18.75B 1.11B 2026-09
Incyte USD 5.64B 701.49M 2026-09
Ionis Pharmaceuticals USD 439.74M 51.68M 2026-06
J&J USD 81.53B 3.44B 2026-09
Kyowa Hakko Kirin JPY 908.54B 7.62B 2026-09
Merck USD 41.93B 3.94B 2026-06
Moderna USD 6.76B 647M 2026-06
Neurocrine Biosciences USD 3.88B 185.1M 2026-09
Novartis USD 37.23B 4.72B 2026-09
Novartis USD 37.56B 1.36B 2026-09
Pfizer USD 85.19B 4.91B 2026-06
Puma Biotechnology USD 115.27M 10.55M 2025-09
Regeneron Pharmaceuticals USD 33.5B 1.79B 2026-09
Roche Holding CHF 32.69B 1.11B 2026-06
Sanofi EUR 69.57B 3.58B 2026-06
Sarepta Therapeutics USD 1.53B 22.7M 2026-06
Teva Pharmaceutical Industries USD 7.75B 475M 2026-06
Ultragenyx Pharmaceutical USD -291M 55M 2026-06
United Therapeutics USD 6.4B 499.2M 2026-06
Vertex Pharmaceuticals USD 20.25B 886M 2026-06